James Hok-Leung Tsu
University of Hong Kong
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by James Hok-Leung Tsu.
Quality of Life Research | 2015
Carlos K. H. Wong; Edmond P. H. Choi; James Hok-Leung Tsu; Brian Sh Ho; Ada T.L. Ng; Wy Chin; Mk Yiu
PurposeThe aim of the study was to assess the validity, reliability and sensitivity of the FACT-P (version 4) in Chinese males with prostate cancer.MethodsConstruct validity was assessed using Spearman’s correlation test against the 12-item Short Form Health Survey (SF-12v2). Internal consistency and test–retest reliability were assessed using Cronbach’s α coefficient and intra-class correlation coefficient, respectively. Sensitivity was determined by performing known-group comparisons by independent t test.ResultsFACT-P subscale scores had a moderate correlation with the corresponding SF-12v2 domain score that conceptually measures the similar construct providing evidence for adequate construct validity. Internal consistency was acceptable (α: 0.687–0.900) for all subscales aside from the Prostate Cancer Subscale (α: 0.505) and Trial Outcome Index (α: 0.562). FACT-P subscale and total scores showed good test–retest reliability (range 0.753–0.913). All total scales and most of the subscales were sensitive in detecting differences between patients with different levels of functional impairment but not different cancer stages or levels of prostate-specific antigen.ConclusionsThe measure is a valid and reliable measure to assess the health-related quality of life of Chinese males with prostate cancer. The FACT-P is sensitive to detect difference between patients with varying functional status.
Asia-pacific Journal of Clinical Oncology | 2017
Jeremy Yuen-Chun Teoh; James Hok-Leung Tsu; Steffi Kar Kei Yuen; Samson Yun Sang Chan; Peter Ka-Fung Chiu; Ka-Wing Wong; Kwan-Lun Ho; Simon See Ming Hou; Chi-Fai Ng; Ming Kwong Yiu
To evaluate the progression‐free survival (PFS), cancer‐specific survival (CSS) and overall survival (OS) of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy (ADT) in relation to prostate‐specific antigen (PSA) nadir level.
Surgical Practice | 2015
Edmond Ming-Ho Wong; Terence Chun-ting Lai; James Hok-Leung Tsu; Chi-Hang Yee; Chi‐Wai Fan; Fu-Keung Cheung; Chi-Fai Ng; Mk Yiu
Paragangliomas of the urinary bladder (PUB) are uncommon and represent less than 1 per cent of all bladder tumours. They can manifest with classic symptoms and signs similar to those of adrenal pheochromocytoma, but the clinical presentation could be nonspecific. Preoperative diagnosis of this uncommon condition is difficult but important, owing to the potential for catecholamine crisis during surgery. In the present study, we review our experience of four cases of PUB and review the literature on this condition.
Prostate international | 2018
Chiu-Fung Tsang; Terence C.T. Lai; Wayne Lam; Brian Sh Ho; Ada T.L. Ng; Wk Ma; Mk Yiu; James Hok-Leung Tsu
Background To investigate the role of Prostate Specific Antigen density (PSAD) in selecting prostate cancer patients for active surveillance (AS) and to determine a cutoff PSAD in identifying adverse pathological outcomes. Methods Data from 287 patients who underwent radical prostatectomy for prostate cancer were retrospectively reviewed. Six different AS protocols, the University of Toronto; Royal Marsden; John Hopkins; University of California San Francisco (UCSF); Memorial Sloan Kettering Cancer Center (MSKCC) and Prostate Cancer Research International: Active Surveillance (PRIAS), were applied to the cohort. Pre-operative demographics and pathological outcomes were analysed. Statistical analyses on the predictive factors of adverse pathological outcomes and significance of PSAD were performed. A cutoff PSAD with best balance between sensitivity and specificity in identifying adverse pathological outcome was determined. Results PSAD predicted adverse pathological outcomes better than Prostate Specific Antigen (PSA) level alone. The PSAD was significantly lower (0.12–0.13 ng/dl/ml) in protocols including PSAD (the John Hopkins and PRIAS) compared with the other four protocols not including PSAD as a selection criteria (0.21–0.25 ng/dl/dl, P = 0.00). PSAD predicted adverse pathological outcomes in all protocols not incorporating PSAD as an inclusion criteria (P = 0.00–0.02). By the receiver operator characteristics curve analysis, it was found that a PSAD level of 0.19 ng/ml/ml had the best balance between sensitivity and specificity in predicting pathological adverse disease (Area under curve = 0.63, P = 0.004). Conclusion PSAD is necessary in selecting prostate cancer patients for active surveillance. It predicts adverse pathological outcomes in patients eligible for active surveillance better than PSA level alone. A PSAD cutoff at 0.19 ng/ml/ml has the best balance between sensitivity and specificity in predicting pathological adverse disease. We recommend using AS protocol incorporating PSAD as a selection criteria (in particular the PRIAS protocol with a cutoff PSAD at 0.2 ng/ml/ml) when recruiting prostate cancer patients for AS.
Asian Journal of Urology | 2017
Ka Wing Wong; Terence Chun-ting Lai; Ada Tsui-lin Ng; Brian Sze-ho Ho; James Hok-Leung Tsu; Chiu Fung Tsang; Wk Ma; Ming Kwong Yiu
Perineal hernia is a rare complication of anterior exenteration. We reported this complication after an anterior exenteration for bladder cancer with bleeding complication requiring packing and second-look laparotomy. Perineal approach is a simple and effective method for repair of perineal hernia.
Asian Journal of Endoscopic Surgery | 2015
Chi-Hang Yee; Joseph Hon-ming Wong; Peter Ka-Fung Chiu; Wai-Man Lee; James Hok-Leung Tsu; Jeremy Yuen-chun Teoh; Chi-Fai Ng
The aim of the present study was to establish the safety and efficacy profile of transurethral resection in saline (TURis) bipolar vaporization of the prostate relative to monopolar transurethral resection of prostate (TURP) and to test the hospital stay efficiency after TURis vaporization.
Surgical Practice | 2010
Brian Sh Ho; Kwan-Lun Ho; James Hok-Leung Tsu; Raymond Wai-Man Ng; Wl Law; Po-Chor Tam
Background: Rectourethral fistula is a rare complication of radical prostatectomy. Risk factors include history of pelvic irradiation, cryotherapy, intraoperative rectal injury or transurethral resection of the prostate. Diagnosis of rectourethral fistula requires a high index of suspicion, and complete work‐up with endoscopy and imaging studies. The majority of patients require operative intervention, with approaches ranging from transabdominal, transrectal, transanal, and transperineal routes.
American Journal of Surgery | 2005
Albert C.W. Ting; Stephen W.K. Cheng; Pei Ho; Jensen T. C. Poon; James Hok-Leung Tsu
Urology | 2015
James Hok-Leung Tsu; Wk Ma; Wayne Kwun-Wai Chan; Bosco Lam; Kim-Chung To; Wing-Kin To; Tak-Keung Ng; Pak-Ling Liu; Fu-Keung Cheung; Mk Yiu
Asian Journal of Surgery | 2013
James Hok-Leung Tsu; Chun-Ki Chan; Ringo Wing-Hong Chu; In-Chak Law; Chi-Kwan Kong; Pak-Ling Liu; Fu-Keung Cheung; Mk Yiu